Workflow
凯赛生物(688065)每日收评(06-24)

Group 1 - The stock of Kaisa Bio (688065) has a comprehensive score of 44.02, indicating a weak performance [1] - The main cost analysis shows that the current main cost is 47.52 yuan, with a 5-day main cost of 47.01 yuan, a 20-day main cost of 49.49 yuan, and no instances of price limits in the past year [1] - Northbound capital data indicates a holding of 4.7469 million shares, accounting for 0.81% of the circulating shares, with a net buy of -147,500 shares yesterday [1] Group 2 - Technical analysis identifies a short-term resistance level at 47.40 yuan and a support level at 46.25 yuan, with a mid-term resistance at 48.58 yuan [2] - On June 24, 2025, the net inflow of main funds was 22.2836 million yuan, representing 22% of the total transaction amount, with significant inflows from large orders [2] - The stock is associated with sectors such as chemical products (2.48%), new materials (2.26%), carbon trading (1.38%), and Sci-Tech Innovation Board market-making stocks (2.44%) [2]